TXNIP interaction with the Her-1/2 pathway contributes to overall survival in breast cancer
Authors:
Open Access
- 30 December 2014
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (5) , 3003-3012
Abstract
Previous studies have indicated that Her-2 induction causes a strong decrease in thioredoxin interaction protein (TXNIP) in breast cancer cells. However, little is known regarding the prognostic value of TXNIP in clinical breast cancer patients with anti-Her-2 treatment. Using a tissue microarray, we detected TXNIP and p27 expression in breast cancer tissue, as well as corresponding noncancerous tissues. We found that TXNIP expression was associated with better overall survival (OS) in these 150 breast cancer patients and that TXNIP and Her-2 expression status were significantly inversely correlated (r=-0.334, P<0.001). These results were validated in another 101 breast cancer tissue samples (r=-0.422, P<0.001). Moreover, TXNIP expression increased significantly following treatment of the human breast cancer cell lines BT474 and SK-BR-3 with a Her-1/2 inhibitor. Furthermore, TXNIP transfection induced p27 expression and G1 cell cycle arrest and apoptosis. Taken together, our findings suggest that TXNIP plays a critical role in anti-Her-1/Her-2 treatment and may be a potential prognostic marker in breast cancer.Keywords
This publication has 19 references indexed in Scilit:
- Transcriptional regulation of the p73 gene by Nrf-2 and promoter CpG methylation in human breast cancerOncotarget, 2014
- Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancerBreast Cancer Research, 2010
- p27Kip1 as a prognostic factor in breast cancer: a systematic review and meta‐analysisJournal of Cellular and Molecular Medicine, 2010
- The NLRP3 Inflammasome: A Sensor for Metabolic Danger?Science, 2010
- Effects of the combined blockade of EGFR and ErbB-2 on signal transduction and regulation of cell cycle regulatory proteins in breast cancer cellsBreast Cancer Research and Treatment, 2009
- Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachmentNature, 2009
- The function of p27KIP1during tumor developmentExperimental & Molecular Medicine, 2009
- Diverse functions of VDUP1 in cell proliferation, differentiation, and diseases.2007
- Hyperglycemia regulates thioredoxin-ROS activity through induction of thioredoxin-interacting protein (TXNIP) in metastatic breast cancer-derived cells MDA-MB-231BMC Cancer, 2007
- Redox-sensitive signaling factors as a novel molecular targets for cancer therapyDrug Resistance Updates, 2005